CTAS vs. CI

In the year-to-date period, CTAS achieves a 14.28% return, which is significantly lower than CI's 22.04% return. Over the past 10 years, CTAS has outperformed CI with an annualized return of 27.57%, while CI has yielded a comparatively lower 10.65% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Cintas Corporation (CTAS) and Cigna Corporation (CI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current CTAS Sharpe Ratio is 1.04, which is higher than the CI Sharpe Ratio of -0.12. The chart below compares the historical Sharpe Ratios of CTAS and CI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

CTAS's dividend yield for the trailing twelve months is around 0.72%, less than CI's 1.70% yield.

The maximum CTAS drawdown since its inception was -65.32%, smaller than the maximum CI drawdown of -84.34%. Use the drawdown chart below to compare losses from any high point for CTAS and CI. For additional features, visit the drawdowns tool.

Cintas Corporation (CTAS) has a higher volatility of 12.05% compared to Cigna Corporation (CI) at 8.01%. This indicates that CTAS's price experiences larger fluctuations and is considered to be riskier than CI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Cintas Corporation and Cigna Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.